Genetic mechanisms of resistance apply to BRAF alone: amplification of gene copying and alternative splicing, which were detected in 20%–32% of melanoma cases [18,19], or genes encoding proteins directly, and indirectly interacting with BRAF kinase. This evidence concerns the gene BRAF and melanoma.